Walleye Capital’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-211,797
| Closed | -$290K | – | 2288 |
|
|
2025
Q1 | $290K | Sell |
211,797
-75,255
| -26% | -$103K | ﹤0.01% | 1276 |
|
|
2024
Q4 | $887K | Buy |
287,052
+144,476
| +101% | +$446K | ﹤0.01% | 973 |
|
|
2024
Q3 | $1.1M | Buy |
+142,576
| New | +$1.1M | ﹤0.01% | 1005 |
|
|
2024
Q2 | – | Sell |
-13,172
| Closed | -$105K | – | 2970 |
|
|
2024
Q1 | $105K | Sell |
13,172
-8,990
| -41% | -$71.4K | ﹤0.01% | 1999 |
|
|
2023
Q4 | $219K | Buy |
+22,162
| New | +$219K | ﹤0.01% | 1466 |
|
|
2023
Q1 | – | Sell |
-289,867
| Closed | -$2.1M | – | 2710 |
|
|
2022
Q4 | $2.1M | Sell |
289,867
-114,780
| -28% | -$832K | 0.04% | 453 |
|
|
2022
Q3 | $1.47M | Buy |
+404,647
| New | +$1.47M | 0.03% | 565 |
|
|
2021
Q4 | – | Sell |
-41,415
| Closed | -$535 | – | 2262 |
|
|
2021
Q3 | $535 | Buy |
+41,415
| New | +$535 | 0.02% | 740 |
|